Skip to main content
. 2008 Aug 10;5(2):73–94. doi: 10.1900/RDS.2008.5.73

Table 4. Combined summary data for clinical trials with liraglutide.

graphic file with name RevDiabeticStud-05-073-006.jpg

Legend

Only highest doses from these trials are shown. MET: metformin. FPG: fasting plasma glucose. NR: not reported. 1 Fraction of patients (in %) with HbA1c ≤ 7% at the end of the study. 2 Fraction of patients with adverse effects (in %). a Placebo-subtracted change. b Change vs. MET monotherapy.